Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Purpose of the study is to evaluate the safety and efficacy of different re-introduction
regimens in anti-TB drug induced liver damage. There is no consensus how best to treat such
patients who developed drug induced liver damage.
Phase:
Phase 4
Details
Lead Sponsor:
All India Institute of Medical Sciences, New Delhi